Compare, Analyse Novartis with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ACTAVIS (US) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   ACTAVIS
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ACTAVIS
Dec-18
NOVARTIS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs98014,578-   
Low Rs6009,779-   
Sales per share (Unadj.) Rs198.73,576.0-  
Earnings per share (Unadj.) Rs21.0-1,151.8-  
Cash flow per share (Unadj.) Rs22.3376.8-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.514,749.5-  
Shares outstanding (eoy) m24.69332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.4 116.7%   
Avg P/E ratio x37.7-10.6 -356.4%  
P/CF ratio (eoy) x35.532.3 109.8%  
Price / Book Value ratio x2.60.8 311.2%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5084,050,639 0.5%   
No. of employees `0000.616.9 3.4%   
Total wages/salary Rs m1,1710-   
Avg. sales/employee Rs Th8,445.470,378.3 12.0%   
Avg. wages/employee Rs Th2,015.70-   
Avg. net profit/employee Rs Th891.0-22,668.9 -3.9%   
INCOME DATA
Net Sales Rs m4,9071,189,393 0.4%  
Other income Rs m78322,745 3.4%   
Total revenues Rs m5,6891,212,138 0.5%   
Gross profit Rs m12331,168 0.4%  
Depreciation Rs m32508,440 0.0%   
Interest Rs m1668,635 0.0%   
Profit before tax Rs m858-523,161 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0133,427 0.0%   
Tax Rs m340-6,630 -5.1%   
Profit after tax Rs m518-383,104 -0.1%  
Gross profit margin %2.52.6 95.5%  
Effective tax rate %39.61.3 3,128.0%   
Net profit margin %10.6-32.2 -32.8%  
BALANCE SHEET DATA
Current assets Rs m8,055487,827 1.7%   
Current liabilities Rs m1,850431,548 0.4%   
Net working cap to sales %126.44.7 2,672.3%  
Current ratio x4.41.1 385.1%  
Inventory Days Days4520 229.9%  
Debtors Days Days3466 51.1%  
Net fixed assets Rs m150134,633 0.1%   
Share capital Rs m1230-   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,5924,905,689 0.2%   
Long term debt Rs m01,727,471 0.0%   
Total assets Rs m9,8247,668,708 0.1%  
Interest coverage x54.9-6.6 -829.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.2 322.0%   
Return on assets %5.4-4.1 -132.5%  
Return on equity %6.8-7.8 -87.3%  
Return on capital %11.5-4.8 -237.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,943424,925 -0.5%  
From Investments Rs m2,742233,441 1.2%  
From Financial Activity Rs m-298-729,299 0.0%  
Net Cashflow Rs m501-70,579 -0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 75.34 Rs / USD

Compare NOVARTIS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: BIOCON   WYETH LTD  STERLING BIOTECH  ALKEM LABORATORIES  ELDER PHARMA  



Today's Market

Sensex Zooms 1,028 Points; Oil & Gas, FMCG and Metal Stocks Rally(Closing)

Indian share markets continued to trade in the green during closing hours and ended their day on a strong note, tracking global cues.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

NOVARTIS SHARE PRICE


Mar 31, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

OTHER USEFUL LINKS

MARKET STATS